Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company based in the United States. It focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The company is engaged in developing an investigational metoclopramide nasal spray called Gimoti, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel formulation of drug which is designed to provide systemic delivery of metoclopramide through nasal spray administration to treat the symptoms associated with acute and recurrent diabetic gastroparesis and it is also available in oral tablet and injection dose forms. The company primarily operates in the US.